D'Antiga et al identified prognostic factors for patients with hepatoblastoma. These can help identify a patient with unresectable tumor who may benefit from liver transplantation. The authors are from the University of Padova and Istituto Oncologico Veneto IRCSS in Italy.
Patient selection: no distant metastases
Parameters for evaluation at presentation:
(1) age of the patient
(2) PRETEXT group
(3) number of tumor foci
(4) vascular involvement (portal vein, hepatic vein, inferior vena cava)
(5) serum alpha-fetoprotein (AFP)
Parameter |
Finding |
Points |
age |
younger (median 0.7 years) |
0 |
|
older (median 4.2 years) |
1 |
PRETEXT group |
1 or 2 |
0 |
|
3 or 4 |
1 |
number of tumor foci |
1 |
0 |
|
multifocal |
1 |
vascular involvement |
absent |
0 |
|
present |
1 |
serum AFP |
>= 100 ng/mL |
0 |
|
< 100 ng/mL |
1 |
number of poor prognostic factors =
= SUM(points for all 5 parameters)
Interpretation:
• minimum number of poor prognostic factors: 0
• maximum number: 5
• The higher the score the worse the prognosis and the more likely that the patient will benefit from liver transplantation.
Specialty: Hematology Oncology, Surgery, general, Gastroenterology
ICD-10: ,